These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5707735)

  • 1. [Comparative antiarrhythmic and antitoxic activity of beta-hexamethyleneimino-para-butoxypropiophenone, novocaine amide and quinidine in arrhythmia, induced by calcium chlorides in mice].
    Ammar EM
    Farmakol Toksikol; 1968; 31(5):597-601. PubMed ID: 5707735
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative antiarrhythmic activity of beta-N-hexamethyleneimino-P-butoxypropiophenone, quinidine and novocaine amide in aconitine auricular fibrillation and flutter in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(4):415-8. PubMed ID: 5357458
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiarrhythmic activity of beta-aminoketones in comparison with quinidine and procaine amide in arrhythmia produced by calcium chloride in mice].
    Iur'ev EG; Iur'eva TI
    Farmakol Toksikol; 1973; 36(1):29-32. PubMed ID: 4685151
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative evaluation of the antiarrhythmic effect of derivatives of diphenylacetic acid and novocaine amide].
    Serdiuk EN; Koval'chuk LA
    Farmakol Toksikol; 1971; 34(2):168-70. PubMed ID: 5563386
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of the activity of anti-arrhythmia agents in calcium chloride-induced arrhythmia in mice].
    Gorbunova VV; Gorbunov NP
    Farmakol Toksikol; 1983; 46(3):48-50. PubMed ID: 6861988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethyl-3-ethoxycarbonyl-4-hydroxy-2H-1,2-benzothiazine-2-acetate-1,1-dioxide, a compound producing ventricular arrhythmias.
    Pruss TP
    Toxicol Appl Pharmacol; 1969 Jan; 14(1):1-5. PubMed ID: 4180304
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
    Igarashi T; Hashimoto N
    Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
    Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
    Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined administration of quinidine with the beta-adrenolytic agent inderal and the local anaesthetic of the beta-aminoketone group, hexacaine, in various experimental models of arrhythmias.
    Kudrin AN; Aslaniants ZK; Polevoi LG
    Cor Vasa; 1975; 17(2):133-44. PubMed ID: 1157502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiarrhythmic effect of oxylidine].
    Zaĭtseva KA; Mashkovskiĭ MD
    Farmakol Toksikol; 1970; 33(3):305-9. PubMed ID: 4393832
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metoclopramide and electrocardiographic changes caused by KC1, BaC12, CaC12, MgC12, aconitine, k-strophanthoside, vasopressin and by asphyxia].
    Marmo E; Di Giacomo S; Imperatore A
    Arzneimittelforschung; 1970 Jan; 20(1):12-8. PubMed ID: 4191693
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute coronary care: a year's experience at Napier Hospital.
    Langley RB; Wilson DF; Turner AS
    N Z Med J; 1968 Apr; 67(431):477-9. PubMed ID: 5239791
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the effects of disopyramide, dihydroquinidine and procainamide on 2 types of ventricular arrhythmias].
    Cosnier D; Grimal J; Duchene-Marullaz P
    Therapie; 1971; 26(1):97-107. PubMed ID: 5554772
    [No Abstract]   [Full Text] [Related]  

  • 17. Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice.
    Ferrini R; Miragoli G
    Arzneimittelforschung; 1979; 29(9a):1473-4. PubMed ID: 575496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugs.
    Podrid PJ; Lown B; Graboys TB; Lampert S
    Circulation; 1986 Feb; 73(2 Pt 2):II81-91. PubMed ID: 3943177
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effectiveness of lignocaine, quinidine, propranolol and procainamide as antifibrillatory agents.
    Murnaghan MF
    Br J Pharmacol; 1970 Sep; 40(1):149P. PubMed ID: 5487011
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies with quinidine and digoxin on the cardiac vulnerable period.
    McCawley EL; Dick HL; Reeves M
    Proc West Pharmacol Soc; 1966; 9():9-12. PubMed ID: 5958505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.